Are you ready for the next generation of cell expansion? Automate the right way, right from the start with the Quantum Flex Cell Expansion System. Gain the flexibility, scalability, and connectivity to grow with your therapy, from process development to commercial manufacturing.
Scalability from process development to commercial manufacturing, while supporting both autologous and allogenic applications for a variety of adherent and suspension cell typesTo learn more see the Scale With Quantum Flex infographic in our resources.
Low amounts of starting material mean a reduction or elimination of manual preculture
Billions of suspension cells and hundreds of millions of adherent cells or more, harvested in a volume < 1 L for simplified downstream processing
Visibility and process control, including remote monitoring, fleet management, and user access control
Maintain data integrity and facilitate cGMP compliance including 21 CFR Part 11/Annex 11 regulations
Continuous perfusion over small distances means yields with greater than 90% viability while maintaining target phenotypes
Download a summary of Quantum Flex information.
See the difference for suspension and adherent cells and small clinical batches in this infographic.
Discover how Quantum Flex supports the transition from early process development to commercialization.
Request information on Quantum Flex
Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today.
It is the responsibility of the user to validate the safety and efficacy of the expanded cells for their intended application. Performance varies by user and is dependent on customer processes and materials.